Search

Displaying results 5981 - 5990 of 9328 in total
  1. Drug

    Inixaciclib

    go.drugbank.com/drugs/DB21584
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Inixaciclib is a cyclin dependant kinase inhibitor. Inixaciclib has a monoisotopic molecular weight of 480.24 Da.

  2. Drug

    Abimtrelvir

    go.drugbank.com/drugs/DB21596
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Abimtrelvir is a antiviral 3CL protease inhibitor. Abimtrelvir has a monoisotopic molecular weight of 527.11 Da.

  3. Drug

    Culmerciclib

    go.drugbank.com/drugs/DB21600
    Investigational

    The usage of the INN stem '-ciclib' in the name indicates that Culmerciclib is a cyclin dependant kinase inhibitor. Culmerciclib has a monoisotopic molecular weight of 446.23 Da.

  4. Drug

    Monzosertib

    go.drugbank.com/drugs/DB21619
    Investigational

    The usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor. Monzosertib has a monoisotopic molecular weight of 465.16 Da.

  5. Drug

    Votoplam

    go.drugbank.com/drugs/DB21645
    Investigational

    The usage of the INN stem '-plam' in the name indicates that Votoplam is a SMN2 gene splicing modulator. Votoplam has a monoisotopic molecular weight of 419.22 Da.

  6. Drug

    Potrasertib

    go.drugbank.com/drugs/DB21682
    Experimental

    The usage of the INN stem '-sertib' in the name indicates that Potrasertib is a serine/threonine kinase inhibitor. Potrasertib has a monoisotopic molecular weight of 564.19 Da.

  7. Drug

    Tigemocoxib

    go.drugbank.com/drugs/DB21699
    Experimental

    The usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor. Tigemocoxib has a monoisotopic molecular weight of 334.06 Da.

  8. Drug

    R1204

    go.drugbank.com/drugs/DB05118
    Experimental

    It is developed for the treatment of depression.

  9. Drug

    AZD 3355

    go.drugbank.com/drugs/DB05404
    Investigational

    AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.

  10. Drug

    Zofin

    go.drugbank.com/drugs/DB16519
    Investigational

    Zofin, previously known as Organicell Flow, is a nanoparticle-based therapeutic derived from perinatal sources which is manufactured in a way that retains the naturally occurring microRNAs without the